Michael J. Capaldi

Michael J. Capaldi

Director/Board Member at Stealthyx Therapeutics Ltd.

66 year
Health Technology
Commercial Services
Consumer Services

Profile

Michael J.
Capaldi
is currently a Director at Stealthyx Therapeutics Ltd.
and Synaptica Ltd.
He previously held positions as Non-Executive Chairman at Mindweavers Plc, Research Scientist at Ciba-Geigy Corp., Principal at GSK Plc, SmithKline Beecham Clinical Laboratories, Oxford Asymmetry International Plc, Scancell Ltd., GE Healthcare Ltd.
(United Kingdom), and Core Group Ltd.
He also served as Chief Executive & Investor Relations Officer at Hunter-Fleming Ltd.
Capaldi holds a doctorate from The University of Manchester and an undergraduate degree from the University of East Anglia.

Michael J. Capaldi active positions

CompaniesPositionStart
Director/Board Member 31/12/2007
Director/Board Member 30/11/2000
All active positions of Michael J. Capaldi

Former positions of Michael J. Capaldi

CompaniesPositionEnd
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Oxford Asymmetry International Plc Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Michael J. Capaldi's experience

Training of Michael J. Capaldi

The University of Manchester Doctorate Degree
University of East Anglia Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael J. Capaldi's experience

Connections

5

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
GSK PLC

Health Technology

Private companies10
Ciba-Geigy Corp.

Health Technology

Mindweavers Plc

Technology Services

Commercial Services

Oxford Asymmetry International Plc

Process Industries

Commercial Services

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Michael J. Capaldi
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW